Wallace J Mark
George E. Whalen VA Medical Center, 500 Foothill Drive, Salt Lake City, UT 84148, USA.
Curr Pain Headache Rep. 2007 Jun;11(3):208-14. doi: 10.1007/s11916-007-0192-6.
Neuropathic pain encompasses a myriad of painful disease states that are often hard to treat, especially with one single medication. In the comprehensive treatment of neuropathic pain, the concept of complex polypharmacy is a rational approach, accompanied by physical and mental health therapies. Medications primarily used for neuropathic pain generally fall into the categories of anticonvulsants, antidepressants, opioids, and topical agents. Generally, most first-line medications used today show a response rate of approximately 30% to 50% reduction in pain in up to 50% of patients treated. There is no "gold standard" in regard to one medication for neuropathic pain. Some new medications have emerged during the past few years that help to augment the armamentarium of medications used in neuropathic pain. This paper reviews the definition of neuropathic pain and introduces the reader to the evidence-based literature on these new medications available for the treatment of neuropathic pain.
神经病理性疼痛涵盖了众多疼痛性疾病状态,这些疾病往往难以治疗,尤其是仅用一种药物时。在神经病理性疼痛的综合治疗中,联合使用多种药物的理念是一种合理的方法,同时还需结合身心健康疗法。主要用于治疗神经病理性疼痛的药物通常分为抗惊厥药、抗抑郁药、阿片类药物和局部用药。一般来说,如今使用的大多数一线药物在接受治疗的多达50%的患者中显示出疼痛减轻约30%至50%的有效率。对于治疗神经病理性疼痛的单一药物而言,不存在“金标准”。在过去几年中出现了一些新药,有助于扩充用于治疗神经病理性疼痛的药物种类。本文回顾了神经病理性疼痛的定义,并向读者介绍了有关这些可用于治疗神经病理性疼痛的新药的循证文献。